Clinical Trials Browser

Phase 2 × R-CHOP protocol × 90 days × Clear all

NCT07494565 2026-03-27

Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL

Phase 2 Not yet recruiting

Lymphoma, Large B-Cell, Diffuse

NCT06517511 2026-02-12

Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse